Microbio is pleased to announce a new distributor agreement with CareTech International, covering Morocco, Turkey, the United Arab Emirates, Qatar, Kuwait, and Saudi Arabia. This collaboration will enable the widespread distribution of Microbio’s innovative test, InfectID™-BSI, to healthcare providers in these countries facilitating fast and accurate detection of bloodstream infections.
InfectID™-BSI is a groundbreaking molecular diagnostic test that identifies 26 sepsis-associated pathogens, enabling clinicians to administer targeted treatment in less than three hours. The assay works by targeting the pathogen’s DNA ‘fingerprint’. Utilizing melt curve technology, InfectID-BSI™ rapidly identifies sepsis-causing pathogens directly from blood samples. Without the need for enrichment or culture, this CE-marked product offers a powerful tool to improve patient outcomes through quicker and more accurate treatment, playing a crucial role in addressing sepsis, which contributes to millions of deaths globally each year.
Microbio is committed to improving patient outcomes through advanced diagnostic technologies, and this partnership is a significant step in expanding access to InfectID™-BSI across North Africa and the Middle East.
“Partnering with CareTech enables us to broaden our reach in the Middle East and Northern Africa, ensuring that healthcare providers in these important markets have access to our life-saving diagnostic solutions.” said Johan Vanderhoeven, Chief Commercial Officer at Microbio. “We believe that by working together, we can enhance the quality of patient care and drive innovation in infectious disease diagnostics.”
“We are excited to bring Microbio’s cutting-edge InfectID™-BSI test to our region. This product will revolutionize how healthcare providers in the Middle East and North Africa diagnose and treat sepsis, ultimately saving lives,” said Mutaz Al Khalieleh, Sales Director at CareTech International.
Khaled Arwani, Business Director at CareTech International, added, “Our partnership with Microbio is a major milestone in advancing the quality of healthcare across the region. By combining our market expertise with their innovative technology, we can ensure that the InfectID™-BSI test reaches its full potential, providing clinicians with the tools they need to deliver timely and effective treatment.”
CareTech International is well-regarded for its extensive services that support biotech companies, aligning with Microbio’s mission to drive innovation in diagnostics. Their expertise in distribution and deep understanding of the healthcare market makes them an ideal partner for Microbio as it expands its footprint in the MENA region.